Trial intelligence / Profile preview

SNIFFLE-4: LAIV Safety in Children With Asthma

NCT02866942Phase 4Completed

Sponsor
Imperial College London
Start
Oct 2016
Primary completion
Mar 2017
01

Overview

A Phase 4 trial of live attenuated influenza vaccine in influenza, sponsored by Imperial College London. Started Oct 2016; status: completed.

02

Drugs

live attenuated influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02866942.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02866942.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call